Plasma Titers of Antibodies against Epstein-Barr Virus BZLF1 and Risk of Multiple Sclerosis

Publisher： Karger

E-ISSN： 1423-0208|28|4|214-215

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.28, Iss.4, 2007-09, pp. : 214-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Sclerosis, Lymphoma and Nasopharyngeal Carcinoma: The Central Role of Epstein-Barr Virus?

By  

European Neurology, Vol. 63, Iss. 1, 2009-11 ,pp. : 29-35

Karger

Access to resources Recommend Favorite

Epstein-Barr virus reactivation

By Ternak G.  

The Lancet Infectious Diseases, Vol. 3, Iss. 5, 2003-05 ,pp. : 271-271

Elsevier

Access to resources Recommend Favorite

Epstein-Barr virus-recent advances

By Macsween K.F.   Crawford D.H.  

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 131-140

Elsevier

Access to resources Recommend Favorite

Membranoproliferative glomerulonephritis associated with an EpsteinBarr virus infection

By Karamadoukis Lazarus   Toth Tibor   Tomson Charlie  

NDT PLUS, Vol. 1, Iss. 5, 2008-10 ,pp. : 319-321

Oxford University Press

Access to resources Recommend Favorite

Epstein-Barr Virus, Lymphoma Risk and the Potential Role of HIV Infection in IBD Patients Undergoing Immunosuppression

By  

Digestive Diseases, Vol. 28, Iss. 3, 2010-09 ,pp. : 519-524

Karger

Access to resources Recommend Favorite